Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages

被引:40
作者
Eligini, S [1 ]
Colli, S [1 ]
Basso, F [1 ]
Sironi, L [1 ]
Tremoli, E [1 ]
机构
[1] Univ Milan, Inst Pharmacol Sci, E Grossi Paoletti Ctr, I-20133 Milan, Italy
关键词
cyclooxygenase-2; macrophages; oxidized lipoproteins; oxidized phospholipids; atherosclerosis;
D O I
10.1161/01.ATV.19.7.1719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherogenesis involves several aspects of chronic inflammation and wound healing. Indeed, the atheroma is considered a special case of tissue response to injury. Injurious stimuli may include lipoproteins trapped within lesions where protein and lipid moieties have undergone chemical modifications. We have studied the effect of oxidized low density lipoproteins (ox-LDL) on inducible cyclooxygenase (Cox-2) in human monocyte-derived macrophages exposed to bacterial lipopolysaccharide (LPS). Levels of both Cox-2 and constitutive cyclooxygenase (Cox-1) were assessed using Western blot analysis. Prior incubation of macrophages with ox-LDL resulted in a strong inhibition of Cox-2 induced by LPS, without effect on Cox-1. The inhibitory effect was dependent on ox-LDL concentration and its onset was early in time (already detectable 1 hour after macrophage exposure to ox-LDL). Native LDL, and other forms of modified LDL, were without effect. The inhibition was dependent on endocytosis of ox-LDL and could be reproduced using the lipid extract from ox-LDL. Lysophosphatidylcholine, 7 beta-hydroxycholesterol, and 7-oxocholesterol failed to mimic the inhibition, but oxidized arachidonic acid-containing phospholipids, produced by autoxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine, markedly inhibited Cox-2, The observation that ox-LDL downregulates Cox-2 in human macrophages may explain the fact that, within atheromata, the transformation of macrophages into foam cells results in attenuation of the inflammatory response, thus contributing to progression of atherogenesis.
引用
收藏
页码:1719 / 1725
页数:7
相关论文
共 56 条
[1]   DECREASED ARACHIDONATE METABOLISM IN MOUSE PERITONEAL-MACROPHAGES AFTER FOAM CELL-TRANSFORMATION WITH OXIDIZED LOW-DENSITY LIPOPROTEINS [J].
ARAI, H ;
NAGANO, Y ;
NARUMIYA, S ;
KITA, T .
JOURNAL OF BIOCHEMISTRY, 1992, 112 (04) :482-487
[2]   DEGRADATION OF CATIONIZED LOW-DENSITY LIPOPROTEIN AND REGULATION OF CHOLESTEROL-METABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS [J].
BASU, SK ;
GOLDSTEIN, JL ;
ANDERSON, RGW ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3178-3182
[3]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[4]   Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein [J].
Brand, K ;
Eisele, T ;
Kreusel, U ;
Page, M ;
Page, S ;
Haas, M ;
Gerling, A ;
Kaltschmidt, C ;
Neumann, FJ ;
Mackman, N ;
Baeuerle, PA ;
Walli, AK ;
Neumeier, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1901-1909
[5]  
Brown AJ, 1997, J LIPID RES, V38, P1730
[6]   7-BETA-HYDROPEROXYCHOLEST-5-EN-3-BETA-OL, A COMPONENT OF HUMAN ATHEROSCLEROTIC LESIONS, IS THE PRIMARY CYTOTOXIN OF OXIDIZED HUMAN LOW-DENSITY-LIPOPROTEIN [J].
CHISOLM, GM ;
MA, GP ;
IRWIN, KC ;
MARTIN, LL ;
GUNDERSON, KG ;
LINBERG, LF ;
MOREL, DW ;
DICORLETO, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11452-11456
[7]  
CLINTON SK, 1992, AM J PATHOL, V140, P301
[8]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138
[9]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[10]  
FONG LG, 1991, J LIPID RES, V32, P1899